ReposiTrak (TRAK) CEO and 10% owner Randall Fields discloses planned share sale
Rhea-AI Filing Summary
ReposiTrak, Inc. insider Randall K. Fields, who serves as Chief Executive Officer, director, and a 10% owner, reported an automatic sale of company stock. On 12/31/2025, an affiliated entity, RK Fields Charitable 2022, LLC, sold 7,500 shares of common stock at a weighted average price of $12.3449 per share under a pre-established Rule 10b5-1 trading plan. The filing states that this trading plan was set up to help Mr. Fields meet certain charitable commitments. After the reported transaction, Mr. Fields continues to report substantial holdings in ReposiTrak common and preferred stock through multiple entities and family holdings.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did ReposiTrak (TRAK) report for Randall K. Fields?
The filing reports that 7,500 shares of ReposiTrak common stock were sold on 12/31/2025 at a weighted average price of $12.3449 per share.
Was the ReposiTrak (TRAK) insider sale made under a Rule 10b5-1 trading plan?
Yes. The sale occurred automatically under a Rule 10b5-1 trading plan adopted by Randall K. Fields in his capacity as trustee of the 2022 RK Fields Charitable Remainder Unitrust.
Why was the Rule 10b5-1 plan established for the ReposiTrak (TRAK) insider?
The filing states that the trading plan was established to enable Randall K. Fields to meet some of his charitable commitments.
What is Randall K. Fields’ role and relationship to ReposiTrak (TRAK)?
Randall K. Fields is reported as a Director, Chief Executive Officer, and a 10% owner of ReposiTrak, Inc.
How many ReposiTrak (TRAK) shares does Randall K. Fields report owning after the transaction?
After the reported sale, the filing shows 160,000 shares of common stock held indirectly by RK Fields Charitable 2022, LLC, along with additional common and Series B preferred stock positions held directly, through entities such as Riverview Financial Corp. and Fields Management, Inc., and by his spouse.
At what price range were the ReposiTrak (TRAK) shares sold in this insider transaction?
The filing notes that the 7,500 shares were sold in multiple transactions at prices ranging from $12.16 to $12.58 per share, with a weighted average price of $12.3449.